查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1697157

全球 IVD 試劑市場：產業分析、規模、佔有率、成長、趨勢和預測（2025-2032 年）

IVD Reagents Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 182 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

預計2025年全球IVD試劑市場規模將達到774億美元，到2032年將達到1,195億美元，預測期間（2025-2032年）的複合年成長率為6.4%。

體外診斷（IVD）試劑是診斷測試中使用的關鍵組件，有助於檢測、監測和治療各種疾病。這些試劑廣泛應用於臨床實驗室、醫院和研究機構，從傳染病檢查到腫瘤學和基因檢測。對個人化醫療的關注度不斷提高、慢性病盛行率不斷上升以及對就地檢驗的需求不斷增加是推動市場發展的關鍵因素。分子診斷和免疫測量等診斷技術的進步進一步推動了對體外診斷試劑的需求。

全球體外診斷（IVD）試劑市場受到多種因素的推動，包括感染疾病、癌症和糖尿病等慢性疾病以及對疾病早期檢測的需求。次世代定序(NGS) 和聚合酵素鏈鎖反應(PCR) 等先進診斷技術的採用正在加速對高品質試劑的需求。此外，醫療保健基礎設施的擴張，尤其是在新興國家，正在促進人們更多地獲得診斷服務。政府推動疾病早期診斷的措施和不斷上漲的醫療成本也促進了市場的成長。

儘管體外診斷市場預計將迎來良好的成長前景，但它仍面臨著許多挑戰，包括嚴格的監管要求以及與先進診斷測試相關的高成本。新型試劑監管核准的複雜性可能會延遲市場進入並影響創新解決方案的開發。此外，對測試結果的可重複性和準確性的擔憂可能會阻礙市場採用。特別是在資源有限的環境中，專用試劑的高成本成為其廣泛採用的障礙，限制了某些地區的市場擴張。

由於診斷技術的不斷進步和醫療保健研究投資的增加，體外診斷試劑市場提供了巨大的成長機會。數位化和人工智慧主導的診斷技術的興起有望提高檢測的效率和準確性，為市場進入者開闢新的途徑。此外，家用和自我檢測套組的日益普及檢測套組開啟了新的收益來源。此外，與試劑製造商和醫療保健提供者合作開發適合新興市場的經濟高效的解決方案提供了有利可圖的機會。伴同性診斷在精準醫療中的應用不斷擴大也是一個關鍵的成長領域。

本報告研究了全球 IVD 試劑市場，並根據試劑類型、技術、應用、最終用途行業、區域趨勢和公司概況進行了詳細細分。

目錄

第1章執行摘要

第2章 市場概述

  • 市場範圍和定義
  • 市場動態
  • 宏觀經濟因素
  • COVID-19影響分析
  • 預測因子－相關性和影響力

第3章 增值洞察

第4章全球IVD試劑市場展望

  • 主要亮點
  • 市場規模分析及預測
    • 2019-2024 年歷史市場規模分析
    • 2025-2032年目前市場規模分析與預測
  • 全球IVD試劑市場展望（按試劑類型）
    • 簡介/主要發現
    • 2019 年至 2024 年試劑類型市場規模歷史分析
    • 2025-2032 年試劑類型市場規模分析及預測
    • 按試劑類型分析市場吸引力
  • 全球IVD試劑市場技術展望
    • 簡介/主要發現
    • 2019 年至 2024 年按技術分類的歷史市場規模分析
    • 2025 年至 2032 年按技術分類的當前市場規模分析與預測
    • 依技術進行市場吸引力分析
  • 全球IVD試劑市場應用前景
    • 簡介/主要發現
    • 2019 年至 2024 年按應用分類的歷史市場規模分析
    • 2025 年至 2032 年按應用分類的當前市場規模分析與預測
    • 按應用進行市場吸引力分析
  • 全球IVD試劑市場前景（依最終用途產業）
    • 簡介/主要發現
    • 2019 年至 2024 年按最終用途產業分類的歷史市場規模分析
    • 2025 年至 2032 年終端用途產業市場規模分析及預測
    • 按最終用途行業進行的市場吸引力分析

5. 全球IVD試劑市場區域展望

  • 主要亮點
  • 2019 年至 2024 年各地區歷史市場規模分析
  • 2025 年至 2032 年各地區目前市場規模分析與預測
    • 北美洲
    • 歐洲
    • 東亞
    • 南亞和大洋洲
    • 拉丁美洲
    • 中東和非洲
  • 按地區分析市場吸引力

6. 北美IVD試劑市場展望

7. 歐洲IVD試劑市場展望

第8章東亞IVD試劑市場展望

9. 南亞及大洋洲IVD試劑市場展望

第10章拉丁美洲IVD試劑市場展望

第11章中東和非洲IVD試劑市場展望

第12章競爭格局

  • 2025年市場佔有率分析
  • 市場結構
  • 公司簡介（詳情－概述、財務狀況、策略、最新發展）
    • Abbott
    • Michelin
    • Agilent Technologies
    • Becton Dickinson
    • BioMerieux
    • Bio-Rad
    • Danaher
    • DiaSorin
    • Roche
    • Seegene
    • Sysmex
    • Thermo Fisher Scientific
    • Siemens Helthineers
    • Transasia Bio-Medicals Ltd.
    • Beacon Diagnostics Pvt. Ltd.
    • 其他

第13章 附錄

簡介目錄
Product Code: PMRREP35181

Persistence Market Research has recently released a comprehensive report on the worldwide market for IVD Reagents. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global IVD Reagents market from 2025 to 2032.

Key Insights:

  • IVD Reagents Market Size (2025E): US$ 77.4 Bn
  • Market Value Forecast (2032F): US$ 119.5 Bn
  • Projected Growth (CAGR 2025 to 2032): 6.4%

IVD Reagents Market - Report Scope:

IVD (In Vitro Diagnostics) reagents are essential components used in diagnostic testing, facilitating the detection, monitoring, and treatment of various diseases. These reagents are widely used in clinical laboratories, hospitals, and research institutions for applications ranging from infectious disease testing to oncology and genetic testing. The growing emphasis on personalized medicine, increased prevalence of chronic diseases, and rising demand for point-of-care testing are key factors driving the market. Technological advancements in diagnostic techniques, such as molecular diagnostics and immunoassays, are further fueling the demand for IVD reagents.

Market Growth Drivers:

The global IVD reagents market is driven by several factors, including the rising burden of infectious diseases, chronic conditions such as cancer and diabetes, and the need for early disease detection. The adoption of advanced diagnostic technologies, such as next-generation sequencing (NGS) and polymerase chain reaction (PCR), is accelerating the demand for high-quality reagents. Additionally, the expansion of healthcare infrastructure, particularly in emerging economies, is facilitating greater access to diagnostic services. Government initiatives promoting early disease diagnosis and increased healthcare expenditure are also contributing to market growth.

Market Restraints:

Despite promising growth prospects, the IVD reagents market faces challenges such as stringent regulatory requirements and high costs associated with advanced diagnostic testing. The complexity of regulatory approvals for new reagents can delay market entry, impacting the development of innovative solutions. Additionally, concerns regarding the reproducibility and accuracy of test results may hinder market adoption. The high costs of specialized reagents, particularly in resource-limited settings, pose a barrier to widespread use, limiting market expansion in some regions.

Market Opportunities:

The IVD reagents market presents significant growth opportunities driven by ongoing advancements in diagnostic technologies and increasing investment in healthcare research. The rise of digital and AI-driven diagnostics is expected to enhance the efficiency and accuracy of testing, creating new avenues for market players. The growing trend of at-home and self-testing kits is also opening new revenue streams. Additionally, partnerships between reagent manufacturers and healthcare providers for the development of cost-effective solutions tailored to emerging markets offer lucrative opportunities. The increasing application of companion diagnostics in precision medicine is another key area of growth.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the IVD reagents market globally?
  • How do advancements in molecular diagnostics impact the demand for IVD reagents?
  • Which diagnostic segments are experiencing the highest growth within the market?
  • Who are the key players in the IVD reagents market, and what strategies are they employing to maintain competitiveness?
  • What are the emerging trends and future growth prospects in the global IVD reagents market?

Competitive Intelligence and Business Strategy:

Leading players in the global IVD reagents market, including Roche Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, Danaher Corporation, and Bio-Rad Laboratories, are focusing on research and development, strategic partnerships, and product innovation to strengthen their market position. Companies are investing in automation and digital healthcare solutions to enhance diagnostic capabilities. Collaborations with biotech firms and research institutions for the development of novel reagents are also a key strategy. The expansion of product portfolios through mergers and acquisitions is further shaping the competitive landscape of the market.

Key Companies Profiled:

  • Abbott
  • Agilent Technologies
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Danaher
  • DiaSorin
  • Roche
  • Seegene
  • Sysmex
  • Thermo Fisher Scientific
  • Siemens Healthineers
  • Transasia Bio-Medicals Ltd.
  • Beacon Diagnostics Pvt. Ltd.

IVD Reagents Market Segmentation

By Type of Reagent

  • Antibodies
  • Antigens
  • Oligonucleotides
  • Enzymes
  • Nucleic Acid Probes

By Technology

  • Immunoassay
  • Molecular Diagnostics
  • Clinical Chemistry
  • Hematology
  • Microbiology

By Application

  • Infectious Diseases
  • Cancer/Oncology
  • Cardiology
  • Autoimmune Diseases
  • Genetic Testing
  • Neurology

By End-Use Industry

  • Hospitals
  • Clinical Laboratories
  • Point-of-Care Testing Facilities
  • Home Care Settings

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • The Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global IVD Reagents Market Snapshot, 2025-2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Regulatory Landscape
  • 3.2. Application Epidemiology
  • 3.3. Pipeline Analysis
  • 3.4. Product Adoption Analysis
  • 3.5. Value Chain Analysis
  • 3.6. Key Promotional Strategies by Manufacturers
  • 3.7. PESTLE Analysis
  • 3.8. Porter's Five Force Analysis

4. Global IVD Reagents Market Outlook:

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Bn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
    • 4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025-2032
  • 4.3. Global IVD Reagents Market Outlook: Type of Reagent
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Bn) Analysis, By Type of Reagent, 2019-2024
    • 4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Reagent, 2025-2032
      • 4.3.3.1. Antibodies
      • 4.3.3.2. Antigens
      • 4.3.3.3. Oligonucleotides
      • 4.3.3.4. Enzymes
      • 4.3.3.5. Nucleic Acid Probes
      • 4.3.3.6. Others
    • 4.3.4. Market Attractiveness Analysis: Type of Reagent
  • 4.4. Global IVD Reagents Market Outlook: Technology
    • 4.4.1. Introduction / Key Findings
    • 4.4.2. Historical Market Size (US$ Bn) Analysis, By Technology, 2019-2024
    • 4.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
      • 4.4.3.1. Immunoassay
      • 4.4.3.2. Molecular Diagnostics
      • 4.4.3.3. Clinical Chemistry
      • 4.4.3.4. Hematology
      • 4.4.3.5. Microbiology
      • 4.4.3.6. Others
    • 4.4.4. Market Attractiveness Analysis: Technology
  • 4.5. Global IVD Reagents Market Outlook: Application
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2024
    • 4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
      • 4.5.3.1. Infectious Diseases
      • 4.5.3.2. Cancer/Oncology
      • 4.5.3.3. Cardiology
      • 4.5.3.4. Autoimmune Diseases
      • 4.5.3.5. Genetic Testing
      • 4.5.3.6. Neurology
      • 4.5.3.7. Others
    • 4.5.4. Market Attractiveness Analysis: Application
  • 4.6. Global IVD Reagents Market Outlook: End-Use Industry
    • 4.6.1. Introduction / Key Findings
    • 4.6.2. Historical Market Size (US$ Bn) Analysis, By End-Use Industry, 2019-2024
    • 4.6.3. Current Market Size (US$ Bn) Analysis and Forecast, By End-Use Industry, 2025-2032
      • 4.6.3.1. Hospitals
      • 4.6.3.2. Point-Of-Care Testing Facilities
      • 4.6.3.3. Home Care Settings
      • 4.6.3.4. Others
    • 4.6.4. Market Attractiveness Analysis: End-Use Industry

5. Global IVD Reagents Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
  • 5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America IVD Reagents Market Outlook:

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 6.2.1. By Country
    • 6.2.2. By Type of Reagent
    • 6.2.3. By Technology
    • 6.2.4. By Application
    • 6.2.5. By Application
    • 6.2.6. By End-Use Industry
  • 6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Reagent, 2025-2032
    • 6.4.1. Antibodies
    • 6.4.2. Antigens
    • 6.4.3. Oligonucleotides
    • 6.4.4. Enzymes
    • 6.4.5. Nucleic Acid Probes
    • 6.4.6. Others
  • 6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
    • 6.5.1. Immunoassay
    • 6.5.2. Molecular Diagnostics
    • 6.5.3. Clinical Chemistry
    • 6.5.4. Hematology
    • 6.5.5. Microbiology
    • 6.5.6. Others
  • 6.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 6.6.1. Infectious Diseases
    • 6.6.2. Cancer/Oncology
    • 6.6.3. Cardiology
    • 6.6.4. Autoimmune Diseases
    • 6.6.5. Genetic Testing
    • 6.6.6. Neurology
    • 6.6.7. Others
  • 6.7. Current Market Size (US$ Bn) Analysis and Forecast, By End-Use Industry, 2025-2032
    • 6.7.1. Hospitals
    • 6.7.2. Point-Of-Care Testing Facilities
    • 6.7.3. Home Care Settings
    • 6.7.4. Others
  • 6.8. Market Attractiveness Analysis

7. Europe IVD Reagents Market Outlook:

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Type of Reagent
    • 7.2.3. By Technology
    • 7.2.4. By Application
    • 7.2.5. By Application
    • 7.2.6. By End-Use Industry
  • 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Turkey
    • 7.3.8. Rest of Europe
  • 7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Reagent, 2025-2032
    • 7.4.1. Antibodies
    • 7.4.2. Antigens
    • 7.4.3. Oligonucleotides
    • 7.4.4. Enzymes
    • 7.4.5. Nucleic Acid Probes
    • 7.4.6. Others
  • 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
    • 7.5.1. Immunoassay
    • 7.5.2. Molecular Diagnostics
    • 7.5.3. Clinical Chemistry
    • 7.5.4. Hematology
    • 7.5.5. Microbiology
    • 7.5.6. Others
  • 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 7.6.1. Infectious Diseases
    • 7.6.2. Cancer/Oncology
    • 7.6.3. Cardiology
    • 7.6.4. Autoimmune Diseases
    • 7.6.5. Genetic Testing
    • 7.6.6. Neurology
    • 7.6.7. Others
  • 7.7. Current Market Size (US$ Bn) Analysis and Forecast, By End-Use Industry, 2025-2032
    • 7.7.1. Hospitals
    • 7.7.2. Point-Of-Care Testing Facilities
    • 7.7.3. Home Care Settings
    • 7.7.4. Others
  • 7.8. Market Attractiveness Analysis

8. East Asia IVD Reagents Market Outlook:

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Type of Reagent
    • 8.2.3. By Technology
    • 8.2.4. By Application
    • 8.2.5. By Application
    • 8.2.6. By End-Use Industry
  • 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Reagent, 2025-2032
    • 8.4.1. Antibodies
    • 8.4.2. Antigens
    • 8.4.3. Oligonucleotides
    • 8.4.4. Enzymes
    • 8.4.5. Nucleic Acid Probes
    • 8.4.6. Others
  • 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
    • 8.5.1. Immunoassay
    • 8.5.2. Molecular Diagnostics
    • 8.5.3. Clinical Chemistry
    • 8.5.4. Hematology
    • 8.5.5. Microbiology
    • 8.5.6. Others
  • 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 8.6.1. Infectious Diseases
    • 8.6.2. Cancer/Oncology
    • 8.6.3. Cardiology
    • 8.6.4. Autoimmune Diseases
    • 8.6.5. Genetic Testing
    • 8.6.6. Neurology
    • 8.6.7. Others
  • 8.7. Current Market Size (US$ Bn) Analysis and Forecast, By End-Use Industry, 2025-2032
    • 8.7.1. Hospitals
    • 8.7.2. Point-Of-Care Testing Facilities
    • 8.7.3. Home Care Settings
    • 8.7.4. Others
  • 8.8. Market Attractiveness Analysis

9. South Asia & Oceania IVD Reagents Market Outlook:

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Type of Reagent
    • 9.2.3. By Technology
    • 9.2.4. By Application
    • 9.2.5. By Application
    • 9.2.6. By End-Use Industry
  • 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Reagent, 2025-2032
    • 9.4.1. Antibodies
    • 9.4.2. Antigens
    • 9.4.3. Oligonucleotides
    • 9.4.4. Enzymes
    • 9.4.5. Nucleic Acid Probes
    • 9.4.6. Others
  • 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
    • 9.5.1. Immunoassay
    • 9.5.2. Molecular Diagnostics
    • 9.5.3. Clinical Chemistry
    • 9.5.4. Hematology
    • 9.5.5. Microbiology
    • 9.5.6. Others
  • 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 9.6.1. Infectious Diseases
    • 9.6.2. Cancer/Oncology
    • 9.6.3. Cardiology
    • 9.6.4. Autoimmune Diseases
    • 9.6.5. Genetic Testing
    • 9.6.6. Neurology
    • 9.6.7. Others
  • 9.7. Current Market Size (US$ Bn) Analysis and Forecast, By End-Use Industry, 2025-2032
    • 9.7.1. Hospitals
    • 9.7.2. Point-Of-Care Testing Facilities
    • 9.7.3. Home Care Settings
    • 9.7.4. Others
  • 9.8. Market Attractiveness Analysis

10. Latin America IVD Reagents Market Outlook:

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Type of Reagent
    • 10.2.3. By Technology
    • 10.2.4. By Application
    • 10.2.5. By Application
    • 10.2.6. By End-Use Industry
  • 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Reagent, 2025-2032
    • 10.4.1. Antibodies
    • 10.4.2. Antigens
    • 10.4.3. Oligonucleotides
    • 10.4.4. Enzymes
    • 10.4.5. Nucleic Acid Probes
    • 10.4.6. Others
  • 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
    • 10.5.1. Immunoassay
    • 10.5.2. Molecular Diagnostics
    • 10.5.3. Clinical Chemistry
    • 10.5.4. Hematology
    • 10.5.5. Microbiology
    • 10.5.6. Others
  • 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 10.6.1. Infectious Diseases
    • 10.6.2. Cancer/Oncology
    • 10.6.3. Cardiology
    • 10.6.4. Autoimmune Diseases
    • 10.6.5. Genetic Testing
    • 10.6.6. Neurology
    • 10.6.7. Others
  • 10.7. Current Market Size (US$ Bn) Analysis and Forecast, By End-Use Industry, 2025-2032
    • 10.7.1. Hospitals
    • 10.7.2. Point-Of-Care Testing Facilities
    • 10.7.3. Home Care Settings
    • 10.7.4. Others
  • 10.8. Market Attractiveness Analysis

11. Middle East & Africa IVD Reagents Market Outlook:

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Type of Reagent
    • 11.2.3. By Technology
    • 11.2.4. By Application
    • 11.2.5. By Application
    • 11.2.6. By End-Use Industry
  • 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Type of Reagent, 2025-2032
    • 11.4.1. Antibodies
    • 11.4.2. Antigens
    • 11.4.3. Oligonucleotides
    • 11.4.4. Enzymes
    • 11.4.5. Nucleic Acid Probes
    • 11.4.6. Others
  • 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
    • 11.5.1. Immunoassay
    • 11.5.2. Molecular Diagnostics
    • 11.5.3. Clinical Chemistry
    • 11.5.4. Hematology
    • 11.5.5. Microbiology
    • 11.5.6. Others
  • 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 11.6.1. Infectious Diseases
    • 11.6.2. Cancer/Oncology
    • 11.6.3. Cardiology
    • 11.6.4. Autoimmune Diseases
    • 11.6.5. Genetic Testing
    • 11.6.6. Neurology
    • 11.6.7. Others
  • 11.7. Current Market Size (US$ Bn) Analysis and Forecast, By End-Use Industry, 2025-2032
    • 11.7.1. Hospitals
    • 11.7.2. Point-Of-Care Testing Facilities
    • 11.7.3. Home Care Settings
    • 11.7.4. Others
  • 11.8. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2025
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Abbott
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Products
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. Michelin
    • 12.3.3. Agilent Technologies
    • 12.3.4. Becton Dickinson
    • 12.3.5. BioMerieux
    • 12.3.6. Bio-Rad
    • 12.3.7. Danaher
    • 12.3.8. DiaSorin
    • 12.3.9. Roche
    • 12.3.10. Seegene
    • 12.3.11. Sysmex
    • 12.3.12. Thermo Fisher Scientific
    • 12.3.13. Siemens Helthineers
    • 12.3.14. Transasia Bio-Medicals Ltd.
    • 12.3.15. Beacon Diagnostics Pvt. Ltd.
    • 12.3.16. Others

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations